Enanta Pharmaceuticals (ENTA) Research & Development (2016 - 2025)
Historic Research & Development for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q4 2025 value amounting to $20.9 million.
- Enanta Pharmaceuticals' Research & Development fell 2457.69% to $20.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $99.9 million, marking a year-over-year decrease of 1858.73%. This contributed to the annual value of $106.7 million for FY2025, which is 1881.41% down from last year.
- According to the latest figures from Q4 2025, Enanta Pharmaceuticals' Research & Development is $20.9 million, which was down 2457.69% from $23.8 million recorded in Q3 2025.
- Enanta Pharmaceuticals' 5-year Research & Development high stood at $48.9 million for Q3 2021, and its period low was $20.9 million during Q4 2025.
- Over the past 5 years, Enanta Pharmaceuticals' median Research & Development value was $36.3 million (recorded in 2023), while the average stood at $36.2 million.
- In the last 5 years, Enanta Pharmaceuticals' Research & Development skyrocketed by 3549.97% in 2021 and then crashed by 3313.79% in 2024.
- Over the past 5 years, Enanta Pharmaceuticals' Research & Development (Quarter) stood at $48.5 million in 2021, then dropped by 15.75% to $40.9 million in 2022, then fell by 11.08% to $36.4 million in 2023, then fell by 23.96% to $27.7 million in 2024, then dropped by 24.58% to $20.9 million in 2025.
- Its Research & Development stands at $20.9 million for Q4 2025, versus $23.8 million for Q3 2025 and $27.2 million for Q2 2025.